
### [MONDO:0018791](http://purl.obolibrary.org/obo/MONDO_0018791)
**Label:** Moyomoya angiopathy

**Subclasses:** [MONDO:0018866](http://purl.obolibrary.org/obo/MONDO_0018866) (Aicardi-Goutieres syndrome), [MONDO:0013059](http://purl.obolibrary.org/obo/MONDO_0013059) (Aicardi-Goutieres syndrome 5), [MONDO:0014143](http://purl.obolibrary.org/obo/MONDO_0014143) (Noonan syndrome 8), [MONDO:0012122](http://purl.obolibrary.org/obo/MONDO_0012122) (MYMY3), [MONDO:0015350](http://purl.obolibrary.org/obo/MONDO_0015350) (17q11.2 microduplication syndrome), [MONDO:0008104](http://purl.obolibrary.org/obo/MONDO_0008104) (Noonan syndrome 1), [MONDO:0020466](http://purl.obolibrary.org/obo/MONDO_0020466) (monosomy X), [MONDO:0020467](http://purl.obolibrary.org/obo/MONDO_0020467) (mosaic monosomy X), [MONDO:0007247](http://purl.obolibrary.org/obo/MONDO_0007247) (basal ganglia calcification, idiopathic, childhood-onset), [MONDO:0011676](http://purl.obolibrary.org/obo/MONDO_0011676) (PHACE syndrome), [MONDO:0013379](http://purl.obolibrary.org/obo/MONDO_0013379) (Noonan syndrome 7), [MONDO:0018827](http://purl.obolibrary.org/obo/MONDO_0018827) (familial Chilblain lupus), [MONDO:0012472](http://purl.obolibrary.org/obo/MONDO_0012472) (Aicardi-Goutieres syndrome 4), [MONDO:0014299](http://purl.obolibrary.org/obo/MONDO_0014299) (Schwannomatosis 2), [MONDO:0011382](http://purl.obolibrary.org/obo/MONDO_0011382) (sickle cell anemia), [MONDO:0012471](http://purl.obolibrary.org/obo/MONDO_0012471) (Aicardi-Goutieres syndrome 3), [MONDO:0018975](http://purl.obolibrary.org/obo/MONDO_0018975) (neurofibromatosis), [MONDO:0014691](http://purl.obolibrary.org/obo/MONDO_0014691) (Noonan syndrome 9), [MONDO:0014693](http://purl.obolibrary.org/obo/MONDO_0014693) (Noonan syndrome 10), [MONDO:0014331](http://purl.obolibrary.org/obo/MONDO_0014331) (Moyamoya disease with early-onset achalasia), [MONDO:0009026](http://purl.obolibrary.org/obo/MONDO_0009026) (Costello syndrome), [MONDO:0011784](http://purl.obolibrary.org/obo/MONDO_0011784) (Moyamoya disease 2), [MONDO:0014367](http://purl.obolibrary.org/obo/MONDO_0014367) (Aicardi-Goutieres syndrome 7), [MONDO:0016820](http://purl.obolibrary.org/obo/MONDO_0016820) (Moyamoya disease), [MONDO:0019499](http://purl.obolibrary.org/obo/MONDO_0019499) (Turner syndrome), [MONDO:0008608](http://purl.obolibrary.org/obo/MONDO_0008608) (down syndrome), [MONDO:0011531](http://purl.obolibrary.org/obo/MONDO_0011531) (Noonan syndrome 2), [MONDO:0013357](http://purl.obolibrary.org/obo/MONDO_0013357) (chromosome 17q11.2 deletion syndrome, 1.4Mb), [MONDO:0010448](http://purl.obolibrary.org/obo/MONDO_0010448) (Moyamoya angiopathy-short stature-facial dysmorphism-hypergonadotropic hypogonadism syndrome), [MONDO:0012429](http://purl.obolibrary.org/obo/MONDO_0012429) (Aicardi-Goutieres syndrome 2), [MONDO:0014007](http://purl.obolibrary.org/obo/MONDO_0014007) (Aicardi-Goutieres syndrome 6), [MONDO:0018208](http://purl.obolibrary.org/obo/MONDO_0018208) (neurofibromatosis type 1 due to NF1 mutation or intragenic deletion), [MONDO:0012547](http://purl.obolibrary.org/obo/MONDO_0012547) (Noonan syndrome 4), [MONDO:0012690](http://purl.obolibrary.org/obo/MONDO_0012690) (Noonan syndrome 5), [MONDO:0012371](http://purl.obolibrary.org/obo/MONDO_0012371) (Noonan syndrome 3), [MONDO:0013542](http://purl.obolibrary.org/obo/MONDO_0013542) (Moyamoya disease 5), [MONDO:0018997](http://purl.obolibrary.org/obo/MONDO_0018997) (Noonan syndrome), [MONDO:0008075](http://purl.obolibrary.org/obo/MONDO_0008075) (neurofibromatosis type 3), [MONDO:0009165](http://purl.obolibrary.org/obo/MONDO_0009165) (Aicardi-Goutieres syndrome 1), [MONDO:0008077](http://purl.obolibrary.org/obo/MONDO_0008077) (neurofibromatosis, type 1), [MONDO:0013186](http://purl.obolibrary.org/obo/MONDO_0013186) (Noonan syndrome 6), [MONDO:0008078](http://purl.obolibrary.org/obo/MONDO_0008078) (neurofibromatosis, familial spinal), [MONDO:0008872](http://purl.obolibrary.org/obo/MONDO_0008872) (microcephalic osteodysplastic primordial dwarfism type II), [MONDO:0018792](http://purl.obolibrary.org/obo/MONDO_0018792) (Moyamoya syndrome), [MONDO:0009649](http://purl.obolibrary.org/obo/MONDO_0009649) (MYMY1), [MONDO:0007039](http://purl.obolibrary.org/obo/MONDO_0007039) (neurofibromatosis type 2), [MONDO:0020472](http://purl.obolibrary.org/obo/MONDO_0020472) (Turner syndrome due to structural X chromosome anomalies), [MONDO:0008080](http://purl.obolibrary.org/obo/MONDO_0008080) (neurofibromatosis, type Iii, mixed central and peripheral), [MONDO:0008081](http://purl.obolibrary.org/obo/MONDO_0008081) (neurofibromatosis, type Iv, of riccardi), 

**Corr. equiv. classes:** [Orphanet:881](http://www.orpha.net/ORDO/Orphanet_881), [Orphanet:3071](http://www.orpha.net/ORDO/Orphanet_3071), [Orphanet:363700](http://www.orpha.net/ORDO/Orphanet_363700), [OMIM:162270](http://purl.obolibrary.org/obo/OMIM_162270), [Orphanet:401945](http://www.orpha.net/ORDO/Orphanet_401945), [OMIM:300845](http://purl.obolibrary.org/obo/OMIM_300845), [Orphanet:42775](http://www.orpha.net/ORDO/Orphanet_42775), [Orphanet:93921](http://www.orpha.net/ORDO/Orphanet_93921), [OMIM:210720](http://purl.obolibrary.org/obo/OMIM_210720), [OMIM:613224](http://purl.obolibrary.org/obo/OMIM_613224), [Orphanet:636](http://www.orpha.net/ORDO/Orphanet_636), [Orphanet:99228](http://www.orpha.net/ORDO/Orphanet_99228), [OMIM:605275](http://purl.obolibrary.org/obo/OMIM_605275), [Orphanet:97685](http://www.orpha.net/ORDO/Orphanet_97685), [Orphanet:481662](http://www.orpha.net/ORDO/Orphanet_481662), [OMIM:615846](http://purl.obolibrary.org/obo/OMIM_615846), [OMIM:218040](http://purl.obolibrary.org/obo/OMIM_218040), [Orphanet:637](http://www.orpha.net/ORDO/Orphanet_637), [OMIM:613706](http://purl.obolibrary.org/obo/OMIM_613706), [OMIM:101000](http://purl.obolibrary.org/obo/OMIM_101000), [Orphanet:99226](http://www.orpha.net/ORDO/Orphanet_99226), [Orphanet:870](http://www.orpha.net/ORDO/Orphanet_870), [Orphanet:232](http://www.orpha.net/ORDO/Orphanet_232), [OMIM:609942](http://purl.obolibrary.org/obo/OMIM_609942), [OMIM:162260](http://purl.obolibrary.org/obo/OMIM_162260), [OMIM:606519](http://purl.obolibrary.org/obo/OMIM_606519), [OMIM:114100](http://purl.obolibrary.org/obo/OMIM_114100), [OMIM:615010](http://purl.obolibrary.org/obo/OMIM_615010), [OMIM:614042](http://purl.obolibrary.org/obo/OMIM_614042), [OMIM:252350](http://purl.obolibrary.org/obo/OMIM_252350), [OMIM:613675](http://purl.obolibrary.org/obo/OMIM_613675), [Orphanet:2573](http://www.orpha.net/ORDO/Orphanet_2573), [Orphanet:280679](http://www.orpha.net/ORDO/Orphanet_280679), [OMIM:610329](http://purl.obolibrary.org/obo/OMIM_610329), [Orphanet:99413](http://www.orpha.net/ORDO/Orphanet_99413), [OMIM:162210](http://purl.obolibrary.org/obo/OMIM_162210), [Orphanet:51](http://www.orpha.net/ORDO/Orphanet_51), [OMIM:225750](http://purl.obolibrary.org/obo/OMIM_225750), [Orphanet:477771](http://www.orpha.net/ORDO/Orphanet_477771), [OMIM:190685](http://purl.obolibrary.org/obo/OMIM_190685), [OMIM:162091](http://purl.obolibrary.org/obo/OMIM_162091), [OMIM:616559](http://purl.obolibrary.org/obo/OMIM_616559), [OMIM:610333](http://purl.obolibrary.org/obo/OMIM_610333), [OMIM:612952](http://purl.obolibrary.org/obo/OMIM_612952), [OMIM:610733](http://purl.obolibrary.org/obo/OMIM_610733), [OMIM:607151](http://purl.obolibrary.org/obo/OMIM_607151), [OMIM:163950](http://purl.obolibrary.org/obo/OMIM_163950), [OMIM:162200](http://purl.obolibrary.org/obo/OMIM_162200), [OMIM:603903](http://purl.obolibrary.org/obo/OMIM_603903), [Orphanet:139474](http://www.orpha.net/ORDO/Orphanet_139474), [OMIM:610181](http://purl.obolibrary.org/obo/OMIM_610181), [OMIM:615670](http://purl.obolibrary.org/obo/OMIM_615670), [OMIM:615750](http://purl.obolibrary.org/obo/OMIM_615750), [OMIM:616564](http://purl.obolibrary.org/obo/OMIM_616564), [OMIM:615355](http://purl.obolibrary.org/obo/OMIM_615355), [OMIM:611553](http://purl.obolibrary.org/obo/OMIM_611553), [Orphanet:2637](http://www.orpha.net/ORDO/Orphanet_2637), [OMIM:608796](http://purl.obolibrary.org/obo/OMIM_608796), [Orphanet:648](http://www.orpha.net/ORDO/Orphanet_648), 

**Class expressions from DL-Learner:**

- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 45.10%
- Thing 45.08%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 45.08%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) 42.71%
- [HP:0000152](http://purl.obolibrary.org/obo/HP_0000152) (Abnormality of head or neck) 36.81%
- [HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument) 36.58%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) 36.22%
- [HP:0000924](http://purl.obolibrary.org/obo/HP_0000924) (Abnormality of the skeletal system) 33.97%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) 33.52%
- [HP:0001507](http://purl.obolibrary.org/obo/HP_0001507) (Growth abnormality) 27.75%
- [HP:0000598](http://purl.obolibrary.org/obo/HP_0000598) (Abnormality of the ear) 24.51%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) 24.50%
- [HP:0000119](http://purl.obolibrary.org/obo/HP_0000119) (Abnormality of the genitourinary system) 23.16%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 19.80%
- [HP:0000818](http://purl.obolibrary.org/obo/HP_0000818) (Abnormality of the endocrine system) 18.10%


